4 December 2024

Last updated: Wednesday 27 November 2024

Research Directory

European Biopharma doesn't skimp on R&D

Commentary: The analysis of biopharma R&D needs to be improved

US selects first drugs for price negotiations

New system for patents takes effect in EU

The EMA reviews the use of real-world evidence

Q2 stocks: Trial results, regulatory nods help European shares

ASCO 2023 Strong data for lung and breast cancer drugs

EU regulators agree Covid-19 vaccine strategy

Step up the fight against superbugs, says EU

European Commission highlights access, supply in pharma proposal